GENE MUTATIONS AND MICRORNA SIGNATURE IN MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE AND LENALIDOMIDE THERAPY

被引：0
|
作者：
Follo, M. Y. [1 ]
Pellagatti, A. [2 ]
Armstrong, R. N. [2 ]
Ratti, S. [1 ]
Mongiorgi, S. [1 ]
Astolfi, A. [3 ,4 ]
Indio, V. [3 ]
De Fanti, S. [5 ]
Russo, D. [6 ]
Gobbi, M. [7 ]
Miglino, M. [7 ]
Bochicchio, M. T. [8 ]
Martinelli, G. [9 ]
Parisi, S. [8 ]
Pession, A. [4 ]
Cavo, M. [8 ]
Cocco, L. [1 ]
Manzoli, L. [1 ]
Boultwood, J. [2 ]
Finelli, C. [8 ]
机构：
[1] Univ Bologna, Dept Biomed & Neuromotor Sci, Cellular Signalling Lab, Bologna, Italy
[2] Univ Oxford, John Radcliffe Hosp, Nuffield Div Clin Lab Sci, Bloodwise Mol Haematol Unit,Dept Med, Oxford, England
[3] Univ Bologna, Interdept Ctr Canc Res G Prodi, Bologna, Italy
[4] Univ Bologna, S Orsola Malpighi Hosp, Pediat Hematol & Oncol Unit, Bologna, Italy
[5] Univ Bologna, Dept Biol Geol & Environm Sci, Bologna, Italy
[6] Univ Brescia, Chair Hematol, Unit Blood Dis & Stem Cell Transplantat, Dept Clin & Expt Sci, Brescia, Italy
[7] Univ Genoa, Dept Hematol & Oncol, Genoa, Italy
[8] Univ Bologna, Inst Hematol L&A Seragnoli, Bologna, Italy
[9] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Meldola, FC, Italy
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CO050
引用
收藏
页码：S43 / S44
页数：2
相关论文
共 50 条
  • [31] Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes
    Unnikrishnan, Ashwin
    Papaemmanuil, Elli
    Beck, Dominik
    Deshpande, Nandan P.
    Verma, Arjun
    Kumari, Ashu
    Woll, Petter S.
    Richards, Laura A.
    Knezevic, Kathy
    Chandrakanthan, Vashe
    Thoms, Julie A. I.
    Tursky, Melinda L.
    Huang, Yizhou
    Ali, Zara
    Olivier, Jake
    Galbraith, Sally
    Kulasekararaj, Austin G.
    Tobiasson, Magnus
    Karimi, Mohsen
    Pellagatti, Andrea
    Wilson, Susan R.
    Lindeman, Robert
    Young, Boris
    Ramakrishna, Raj
    Arthur, Christopher
    Stark, Richard
    Crispin, Philip
    Curnow, Jennifer
    Warburton, Pauline
    Roncolato, Fernando
    Boultwood, Jacqueline
    Lynch, Kevin
    Jacobsen, Sten Eirik W.
    Mufti, Ghulam J.
    Hellstrom-Lindberg, Eva
    Wilkins, Marc R.
    MacKenzie, Karen L.
    Wong, Jason W. H.
    Campbell, Peter J.
    Pimanda, John E.
    CELL REPORTS, 2017, 20 (03): : 572 - 585
  • [32] INTEGRATIVE GENOMICS IDENTIFIES THE MOLECULAR BASIS OF RESISTANCE TO AZACITIDINE THERAPY IN MYELODYSPLASTIC SYNDROMES
    Unnikrishnan, A.
    Papaemmanuil, E.
    Beck, D.
    Verma, A.
    Kumari, A.
    Woll, P.
    Richards, L.
    Knezevic, K.
    Chandrakanthan, V.
    Thoms, J.
    Tursky, M.
    Huang, Y.
    Ali, Z.
    Olivier, J.
    Galbraith, S.
    Kulasekararaj, A.
    Tobiasson, M.
    Karimi, M.
    Pellagatti, A.
    Wilson, S.
    Lindeman, R.
    Young, B.
    Ramakrishna, R.
    Arthur, C.
    Stark, R.
    Crispin, P.
    Curnow, J.
    Warburton, P.
    Roncolato, F.
    Boultwood, J.
    Lynch, K.
    Jacobsen, Se
    Mufti, G.
    Hellstrom-Lindberg, E.
    MacKenzie, K.
    Wong, J.
    Campbell, P.
    Pimanda, J.
    HAEMATOLOGICA, 2016, 101 : 157 - 158
  • [33] Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations
    Mallo, Mar
    del Rey, Monica
    Ibanez, Mariam
    Jose Calasanz, Ma
    Arenillas, Leonor
    Jose Larrayoz, Ma
    Pedro, Carmen
    Jerez, Andres
    Maciejewski, Jaroslaw
    Costa, Dolors
    Nomdedeu, Meritxell
    Diez-Campelo, Maria
    Lumbreras, Eva
    Gonzalez-Martinez, Teresa
    Marugan, Isabel
    Such, Esperanza
    Cervera, Jose
    Cigudosa, Juan C.
    Alvarez, Sara
    Florensa, Lourdes
    Hernandez, Jesus Ma
    Sole, Francesc
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) : 74 - 86
  • [34] Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts
    Martin, Ivan
    Such, Esperanza
    Navarro, Blanca
    Villamon, Eva
    Vicente, Ana
    Mora, Elvira
    Pedrola, Laia
    Ibanez, Mariam
    Lopez-Pavia, Maria
    Tormo, Mar
    Serrano, Alicia
    Angel Sanz, Miguel
    Cervera, Jose
    Sanz, Guillermo
    BLOOD CANCER JOURNAL, 2017, 7
  • [35] Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts
    Iván Martín
    Esperanza Such
    Blanca Navarro
    Eva Villamón
    Ana Vicente
    Elvira Mora
    Laia Pedrola
    Mariam Ibáñez
    María López-Pavía
    Mar Tormo
    Alicia Serrano
    Miguel Ángel Sanz
    José Cervera
    Guillermo Sanz
    Blood Cancer Journal, 7
  • [36] Telomerase Gene Complex Mutations Are Common in Myelodysplastic Syndromes Patients
    Ibanez, Mariam
    Jiang, Jie
    Gandhi, Shreyans
    Syed, Mian
    Smith, Alexander E.
    Best, Steve
    Lea, Nicholas
    Mohamedali, Azim M.
    Ahmed, Momin
    Marsh, Judith C. W.
    Kulasekararaj, Austin G.
    Mufti, Ghulam J.
    BLOOD, 2014, 124 (21)
  • [37] NPM1 GENE MUTATIONS IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES
    Jekic, Biljana
    Bunjevacki, Vera
    Dobricic, Valerija
    Novakovic, Ivana
    Milasin, Jelena
    Popovic, Branka
    Damnjanovic, Tatjana
    Maksimovic, Nela
    Perovic, V.
    Lukovic, Ljiljana
    ARCHIVES OF BIOLOGICAL SCIENCES, 2011, 63 (03) : 649 - 653
  • [38] Mutations in the Telomerase Reverse Transcriptase Gene Predisposes to Myelodysplastic Syndromes
    Calado, Rodricio T.
    Prince, Courtney
    Peterson, Nathan R.
    Young, Neal S.
    Maciejewski, Jaroslaw P.
    BLOOD, 2009, 114 (22) : 172 - 173
  • [39] Azacitidine therapy in high-risk myelodysplastic syndromes (MDS): A single centre experience
    Improta, S.
    Gagliardi, A.
    Villa, M. R.
    Della Cioppa, P.
    Esposito, M.
    Izzo, G. Nitrato
    Mastrullo, L.
    LEUKEMIA RESEARCH, 2013, 37 : S152 - S152
  • [40] Azacitidine Combination with Lenalidomide in Treating Higher-Risk Myelodysplastic Syndromes: A Single-Center, Phase 2 Trial
    Song, Dandan
    Ge, Zheng
    BLOOD, 2023, 142
12345